FDA Approves New Imaging Drug to Help Identify Ovarian Cancer LesionsThe U.S. Food and Drug Administration (FDA) has granted approval for Cytalux® (pafolacianine) for use in adults with ovarian cancer. Cytalux is an imaging drug developed to help surgeons better... By Editorial Team 2 min readBookmark for laterReactions0reactionsComments0 comments
